Skip to Main Content
An official website of the United States government
Login Change: CDAS is now using the NIH Researcher Auth Service (RAS) to manage our existing login options. When logging into CDAS, you will be taken to RAS, where you can select your preferred login provider to access CDAS.

Benign Ovarian Pathology

Purpose

Ovarian cancer screening with transvaginal ultrasound (TVU) and CA-125 in the PLCO trial produced a large number of false-positive tests, often resulting in surgical follow-up. Pathology reports from a selection of these surgical procedures were collected and reviewed to investigate findings that were not collected in the PLCO protocol.

Population

Women with a false positive ovarian screen in any of the first four rounds of screening (T0-T3) with surgical follow-up were selected for review. For this collection, a screen was considered false positive if the woman had a positive TVU or positive CA-125 but was never diagnosed with ovarian cancer. Among the approximately 1,100 women with a false positive screen, 581 were selected for review based on screening results. All women with a positive CA-125, with or without a positive TVU, were selected. Of the over 900 women with a false positive TVU only, 400 were selected at random.

Data Collected

The selected pathology reports from surgeries following false-positive screens were reviewed by NCI pathologists. Findings were recorded onto a form designed by NCI investigators and data from the form was entered into a database.

Benign Ovarian Pathology data can be obtained in the Benign Ovarian Pathology dataset.

Summary

  • 581 Women
  • 181 women with CA-125 positive (47 with both TVU & CA-125 positive)
  • 400 women with TVU positive only
  • Forms used:
    • BOP (PDF - 217 KB)

Available Data

  • Ovarian diagnosis
  • Cystic characteristics (e.g. size, contents)
  • Non-ovarian diagnosis

Main Findings